UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
Top Page
UG Healthcare Corp. Ltd.
(SGX:8K7)
Select Model
Select Model
Rating:49Neutral
Price Target:
S$0.08
▼(-21.00% Downside)
Action:UpgradedDate:01/28/26
The score is primarily held back by weak profitability and deteriorating cash flow despite strong revenue growth, with only partial support from a relatively stable balance sheet. Technicals are moderately positive with price above major moving averages, but valuation is constrained by a negative P/E and lack of dividend data.
Positive Factors
Strong Revenue Growth
Revenue growth of ~51.8% demonstrates durable demand for UG Healthcare's gloves and protective products. Sustained top-line expansion improves ability to absorb fixed costs, supports scale economies, and creates capacity to reinvest in capacity or distribution to drive long‑term margin recovery.
Negative Factors
Negative Profitability Margins
Negative EBIT and net margins point to persistent profitability issues and margin pressure. Over time this weakens internal funding, constrains retained earnings growth, and necessitates sustained cost reductions or pricing power to restore durable operating profitability and shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Revenue growth of ~51.8% demonstrates durable demand for UG Healthcare's gloves and protective products. Sustained top-line expansion improves ability to absorb fixed costs, supports scale economies, and creates capacity to reinvest in capacity or distribution to drive long‑term margin recovery.
Read all positive factors
UG Healthcare Corp. Ltd. (8K7) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$49.28M
Dividend YieldN/A
Average Volume (3M)131.00K
Price to Earnings (P/E)―
Beta (1Y)0.80
Revenue Growth25.06%
EPS Growth37.11%
CountrySG
Employees898
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UG Healthcare Corp. Ltd. Business Overview & Revenue Model
Company Description
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing esse...
How the Company Makes Money
UG Healthcare makes money primarily by selling disposable gloves and other protective healthcare products to customers such as hospitals, clinics, distributors, and industrial/end-user segments, depending on market demand. Revenue is generated fro...
UG Healthcare Corp. Ltd. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.93M | 144.07M | 115.20M | 101.13M | 232.60M | 338.40M |
| Gross Profit | 3.43M | 34.74M | 25.87M | 1.45M | 84.39M | 196.16M |
| EBITDA | -21.20M | 2.47M | -3.94M | -23.97M | 53.37M | 163.04M |
| Net Income | -20.93M | -3.79M | -6.06M | -20.73M | 36.80M | 118.77M |
Balance Sheet | ||||||
| Total Assets | 215.39M | 232.35M | 226.45M | 230.00M | 288.04M | 268.29M |
| Cash, Cash Equivalents and Short-Term Investments | 45.13M | 23.29M | 28.00M | 61.74M | 100.22M | 68.44M |
| Total Debt | 28.46M | 47.36M | 43.72M | 31.13M | 17.98M | 16.74M |
| Total Liabilities | 44.08M | 76.03M | 65.17M | 48.81M | 52.98M | 73.53M |
| Stockholders Equity | 171.94M | 158.73M | 163.39M | 180.84M | 228.90M | 190.64M |
Cash Flow | ||||||
| Free Cash Flow | -36.98M | -8.11M | -20.71M | -47.17M | 31.63M | 61.47M |
| Operating Cash Flow | -34.35M | -4.78M | -18.16M | -39.14M | 53.95M | 81.16M |
| Investing Cash Flow | -2.63M | -3.21M | -22.73M | -8.03M | -21.19M | -18.89M |
| Financing Cash Flow | 4.62M | 3.24M | 8.36M | 8.70M | -973.00K | -3.14M |
UG Healthcare Corp. Ltd. Technical Analysis
Negative
0.10
Price Trends
0.09
Negative
0.09
Negative
0.10
Negative
Market Momentum
>-0.01
Negative
42.49
Neutral
109.17
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Negative. The current price of 0.1 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.09, and above the 200-day MA of 0.10, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.49 is Neutral, neither overbought nor oversold. The STOCH value of 109.17 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:8K7.
UG Healthcare Corp. Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:8K7
UG Healthcare Corp. Ltd.
0.08
-0.02
-23.30%
SG:AP4
Riverstone Holdings
0.70
-0.09
-11.13%
SG:1J5
Hyphens Pharma International Ltd.
0.31
0.05
21.51%
SG:546
Medtecs International Corporation Ltd.
0.12
<0.01
4.46%
SG:BFK
Pharmesis International Ltd.
0.36
-0.25
-40.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.